Clinical Trial

INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE

Study acronym: RECAP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Esophageal Achalasia has been investigated as a potential risk factor for esophageal cancer (EC). Longstanding disease, repeated treatment, age and male sex seem the most relevant risk factors, but no clear effect size estimation from large sample cohorts has been provided so far. The aim of the investigators is to estimate EC risk in large sample-size population, and to provide sub-analyses per cancer type and treatment impact on EC risk.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-08.
Trial Details
NCT Number NCT07022886
Lead Sponsor IRCCS San Raffaele
Collaborators: TriNetX, LLC, Università Vita-Salute San Raffaele
Conditions Achalasia Cardia, Esophageal Cancer (EsC)
Enrollment 47,000 participants
Start Date 2025-06-03
Primary Completion 2025-06-03 (estimated)
Study Completion 2025-09-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-30